134 related articles for article (PubMed ID: 7682163)
1. Purified human oral mucosal Langerhans cells function as accessory cells in vitro.
Barrett AW; Ross DA; Goodacre JA
Clin Exp Immunol; 1993 Apr; 92(1):158-63. PubMed ID: 7682163
[TBL] [Abstract][Full Text] [Related]
2. Antigen presenting capacity of Langerhans cells from rat oral epithelium.
Hasséus B; Dahlgren U; Bergenholtz G; Jontell M
J Oral Pathol Med; 1995 Feb; 24(2):56-60. PubMed ID: 7745542
[TBL] [Abstract][Full Text] [Related]
3. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
Prens EP; Benne K; van Joost T; Benner R
J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cryopreserved human Langerhans cells.
Seo KI; Huh CH; Han JH; Youn JI; Lee CH; Lee WJ; Eun HC
Cryobiology; 2002 Oct; 45(2):118-26. PubMed ID: 12482377
[TBL] [Abstract][Full Text] [Related]
5. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
6. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
7. Oral mucosal Langerhans' cells.
Barrett AW; Cruchley AT; Williams DM
Crit Rev Oral Biol Med; 1996; 7(1):36-58. PubMed ID: 8727106
[TBL] [Abstract][Full Text] [Related]
8. Limitations of flow cytometry in the analysis of CD1a/HLADR+ human oral mucosal Langerhans cells.
Barrett AW; Ross DA; Goodacre JA
Oral Dis; 1995 Mar; 1(1):49-53. PubMed ID: 7553381
[TBL] [Abstract][Full Text] [Related]
9. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
Cruchley AT; Speight PM; Williams DM
Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
[TBL] [Abstract][Full Text] [Related]
10. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cells from oral epithelium are more effective in stimulating allogeneic t-cells in vitro than Langerhans cells from skin epithelium.
Hasséus B; Jontell M; Bergenholtz G; Eklund C; Dahlgren UI
J Dent Res; 1999 Mar; 78(3):751-8. PubMed ID: 10096450
[TBL] [Abstract][Full Text] [Related]
12. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP.
Cruchley AT; Williams DM; Farthing PM; Lesch CA; Squier CA
J Oral Pathol Med; 1989 Oct; 18(9):510-6. PubMed ID: 2481737
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells in nasal mucosa of patients with grass pollen allergy.
Fokkens WJ; Broekhuis-Fluitsma DM; Rijntjes E; Vroom TM; Hoefsmit EC
Immunobiology; 1991 Mar; 182(2):135-42. PubMed ID: 1715843
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin.
Hasséus B; Jontell M; Bergenholtz G; Dahlgren UI
Clin Exp Immunol; 2004 Jun; 136(3):483-9. PubMed ID: 15147350
[TBL] [Abstract][Full Text] [Related]
15. Rapid purification of human Langerhans cells using paramagnetic microbeads.
Simon JC; Dittmar HC; de Roche R; Wilting J; Christ B; Schöpf E
Exp Dermatol; 1995 Jun; 4(3):155-61. PubMed ID: 7551563
[TBL] [Abstract][Full Text] [Related]
16. Analysis of immune cells within the healthy oral mucosa of specific pathogen-free cats.
Arzi B; Murphy B; Baumgarth N; Vapniarsky N; Nemec A; Naydan DK; Cox DP; Verstraete FJ
Anat Histol Embryol; 2011 Feb; 40(1):1-10. PubMed ID: 20809918
[TBL] [Abstract][Full Text] [Related]
17. Antigen-presenting capacity in normal human dermis is mainly subserved by CD1a+ cells.
Sepulveda-Merrill C; Mayall S; Hamblin AS; Breathnach SM
Br J Dermatol; 1994 Jul; 131(1):15-22. PubMed ID: 7519030
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cells and T-lymphocytes in the normal human ectocervix defined by monoclonal antibodies and electron microscopy.
Roig de Vargas-Linares C
Microsc Electron Biol Celular; 1989 Jun; 13(1):53-63. PubMed ID: 2636973
[TBL] [Abstract][Full Text] [Related]
19. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin.
Baadsgaard O; Lisby S; Wantzin GL; Wulf HC; Cooper KD
J Immunol; 1989 Jun; 142(12):4213-8. PubMed ID: 2470820
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane protein A (OmpA) activates human epidermal Langerhans cells.
Godefroy S; Corvaia N; Schmitt D; Aubry JP; Bonnefoy JY; Jeannin P; Staquet MJ
Eur J Cell Biol; 2003 Apr; 82(4):193-200. PubMed ID: 12751905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
